After counterfeit Avastin®—what have we learned and what can be done?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
After counterfeit Avastin®—what have we learned and what can be done?
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 12, Issue 5, Pages 302-308
Publisher
Springer Nature
Online
2015-03-03
DOI
10.1038/nrclinonc.2015.35
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care
- (2014) Ronan J Kelly et al. LANCET ONCOLOGY
- The counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidence
- (2014) Kaliyaperumal Karunamoorthi MALARIA JOURNAL
- Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism
- (2013) Tim K Mackey et al. BMC Medicine
- Growth of Scytalidium sp. in a counterfeit bevacizumab bottle
- (2013) Gerardo Garcia-Aguirre et al. INDIAN JOURNAL OF OPHTHALMOLOGY
- FDA Warning: New Batch of Fake Bevacizumab Found
- (2013) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Stemming the Global Trade in Falsified and Substandard Medicines
- (2013) Lawrence O. Gostin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Contraindicated Use of Bevacizumab and Toxicity in Elderly Patients With Cancer
- (2013) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Digital Social Media, Youth, and Nonmedical Use of Prescription Drugs: The Need for Reform
- (2013) Tim K Mackey et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- The Drug Quality and Security Act — Mind the Gaps
- (2013) Kevin Outterson NEW ENGLAND JOURNAL OF MEDICINE
- Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health
- (2013) Tim K Mackey et al. Globalization and Health
- Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
- (2013) Tariq Almuzaini et al. BMJ Open
- Prices gone wild: Grey market 'scalpers' scoring windfall in American drug market
- (2012) C. Woodward CANADIAN MEDICAL ASSOCIATION JOURNAL
- Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property
- (2012) Tim K. Mackey et al. DRUG DISCOVERY TODAY
- Online Availability and Safety of Drugs in Shortage: A Descriptive Study of Internet Vendor Characteristics
- (2012) Bryan A Liang et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- The "Gray Market" Raises Concerns about Cost, Safety, and Ethics
- (2012) E. T. Rosenthal JNCI-Journal of the National Cancer Institute
- Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
- (2012) Gaurvika ML Nayyar et al. LANCET INFECTIOUS DISEASES
- Fighting Fire with Fire: Rekindling the Bevacizumab Debate
- (2012) Alberto J. Montero et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute Intraocular Inflammation Caused by Endotoxin after Intravitreal Injection of Counterfeit Bevacizumab in Shanghai, China
- (2012) Fenghua Wang et al. OPHTHALMOLOGY
- How to achieve international action on falsified and substandard medicines
- (2012) A. Attaran et al. BMJ-British Medical Journal
- Oncology and the Internet: Regulatory Failure and Reform
- (2012) Tim K. Mackey et al. Journal of Oncology Practice
- Caveat Oncologist: Clinical Findings and Consequences of Distributing Counterfeit Erythropoietin in the United States
- (2012) Zaina P. Qureshi et al. Journal of Oncology Practice
- The global counterfeit drug trade: Patient safety and public health risks
- (2011) Tim K. Mackey et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Shortages of cancer drugs in the USA
- (2011) The Lancet Oncology LANCET ONCOLOGY
- The Shortage of Essential Chemotherapy Drugs in the United States
- (2011) Mandy L. Gatesman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine shortages and suspect online pharmacy sellers
- (2011) Bryan A. Liang et al. VACCINE
- Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study
- (2010) Lucio Crinò et al. LANCET ONCOLOGY
- “Save 30% if you buy today”. Online pharmacies and the enhancement of peripheral thinking in consumers
- (2010) Grazia Orizio et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Impact of poor-quality medicines in the ‘developing’ world
- (2010) Paul N. Newton et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Spurious and counterfeit drugs: a growing industry in the developing world
- (2009) C S Gautam et al. POSTGRADUATE MEDICAL JOURNAL
- Bevacizumab in advanced cancer, too much or too little?
- (2008) A. Jirillo et al. ANNALS OF ONCOLOGY
- The Health Care Systems Of China And India: Performance And Future Challenges
- (2008) Winnie Yip et al. HEALTH AFFAIRS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started